Have your own idea? Try our Stock Screener
Hong Kong (HSI) Drug Retail Industry Analysis
UpdatedAug 04, 2026
DataAggregated Company Financials
Companies6
- 7D5.2%
- 3M-16.2%
- 1Y-25.2%
- YTDn/a
In the last week, the Drug Retail industry is up 6.6%, with JD Health International up 5.3%. During this same period, the Lung Fung Group Holdings underperformed, falling 12%. In the past year, the industry is down 24%. As for the next few years, earnings are expected to grow by 15% per annum.
Industry Valuation and Performance
Has the Hong Kong Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 04 Aug 2026 | HK$204.6b | HK$143.6b | HK$8.7b | 31.8x | 23.4x | 1.4x |
| Thu, 02 Jul 2026 | HK$172.7b | HK$142.8b | HK$8.7b | 28.1x | 19.9x | 1.2x |
| Sat, 30 May 2026 | HK$204.3b | HK$143.1b | HK$8.7b | 34.7x | 23.4x | 1.4x |
| Mon, 27 Apr 2026 | HK$249.7b | HK$140.3b | HK$8.6b | 44.3x | 29x | 1.8x |
| Wed, 25 Mar 2026 | HK$263.3b | HK$140.2b | HK$8.1b | 86.2x | 32.6x | 1.9x |
| Fri, 20 Feb 2026 | HK$331.0b | HK$129.4b | HK$6.9b | 45.7x | 47.8x | 2.6x |
| Sun, 18 Jan 2026 | HK$370.6b | HK$128.0b | HK$6.9b | 50.9x | 54.1x | 2.9x |
| Tue, 16 Dec 2025 | HK$306.4b | HK$126.3b | HK$6.8b | 39.6x | 45.3x | 2.4x |
| Thu, 13 Nov 2025 | HK$340.3b | HK$122.3b | HK$6.1b | 60.3x | 55.4x | 2.8x |
| Sat, 11 Oct 2025 | HK$346.9b | HK$122.3b | HK$6.1b | 64x | 56.4x | 2.8x |
| Mon, 08 Sep 2025 | HK$368.4b | HK$122.3b | HK$6.1b | 66.8x | 59.9x | 3x |
| Wed, 06 Aug 2025 | HK$279.9b | HK$115.2b | HK$4.5b | 51.4x | 62.2x | 2.4x |
| Fri, 04 Jul 2025 | HK$235.6b | HK$115.7b | HK$4.5b | 46.4x | 52.1x | 2x |
| Sun, 01 Jun 2025 | HK$225.6b | HK$114.9b | HK$4.5b | 46.7x | 50.3x | 2x |
| Tue, 29 Apr 2025 | HK$215.6b | HK$109.8b | HK$4.1b | 57.8x | 52.1x | 2x |
| Thu, 27 Mar 2025 | HK$210.6b | HK$110.5b | HK$4.2b | 61.6x | 50.5x | 1.9x |
| Sat, 22 Feb 2025 | HK$239.6b | HK$104.1b | HK$3.6b | 58.6x | 66.5x | 2.3x |
| Mon, 20 Jan 2025 | HK$154.8b | HK$103.3b | HK$3.6b | 37x | 43.3x | 1.5x |
| Wed, 18 Dec 2024 | HK$157.8b | HK$103.6b | HK$3.6b | 37.7x | 44x | 1.5x |
| Fri, 15 Nov 2024 | HK$170.6b | HK$104.4b | HK$3.6b | 40.1x | 47.2x | 1.6x |
| Sun, 13 Oct 2024 | HK$181.8b | HK$105.4b | HK$3.3b | 52.2x | 54.4x | 1.7x |
| Tue, 10 Sep 2024 | HK$138.3b | HK$105.0b | HK$3.3b | 37.1x | 41.5x | 1.3x |
| Thu, 08 Aug 2024 | HK$139.7b | HK$103.1b | HK$2.4b | 42x | 57.9x | 1.4x |
| Sat, 06 Jul 2024 | HK$137.7b | HK$101.9b | HK$2.4b | 41.8x | 57.7x | 1.4x |
| Mon, 03 Jun 2024 | HK$155.3b | HK$102.4b | HK$2.4b | 45.7x | 64.8x | 1.5x |
| Wed, 01 May 2024 | HK$152.9b | HK$103.7b | HK$2.3b | 45.7x | 65.7x | 1.5x |
| Fri, 29 Mar 2024 | HK$158.8b | HK$103.6b | HK$13.7m | 48x | 11570.9x | 1.5x |
| Sun, 25 Feb 2024 | HK$175.9b | HK$105.1b | -HK$1,456,103,459.27 | 58.2x | -120.8x | 1.7x |
| Tue, 23 Jan 2024 | HK$154.5b | HK$105.0b | -HK$1,455,179,765.00 | 49.9x | -106.2x | 1.5x |
| Thu, 21 Dec 2023 | HK$201.3b | HK$105.7b | -HK$1,464,286,842.00 | 62.6x | -137.4x | 1.9x |
| Sat, 18 Nov 2023 | HK$211.7b | HK$102.9b | -HK$1,754,798,457.00 | 86.2x | -120.6x | 2.1x |
| Mon, 16 Oct 2023 | HK$224.7b | HK$102.4b | -HK$1,675,089,400.00 | 104.7x | -134.2x | 2.2x |
| Wed, 13 Sep 2023 | HK$233.4b | HK$102.6b | -HK$1,679,619,096.00 | 84.4x | -139x | 2.3x |
| Fri, 11 Aug 2023 | HK$280.3b | HK$95.9b | -HK$4,161,689,179.00 | 131.4x | -67.3x | 2.9x |
Price to Earnings Ratio
-67.3x
Current Industry PE
- Investors are pessimistic on the Hong Kong Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 23.2x which is lower than its 3-year average PE of 100x.
- The 3-year average PS ratio of 1.9x is higher than the industry's current PS ratio of 1.4x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 14% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Hong Kong Drug Retail compare with similar industries?
| HK Market | 1.76% | |
| Consumer Staples | 4.45% | |
| Food and Staples Retail | 5.66% | |
| Drug Retail | 5.23% | |
| Food Retail | 7.93% | |
| Food Distributors | -0.33% | |
| Big Box Super Stores | -3.34% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6618 JD Health International | HK$39.20 | 3.3% +HK$4.0b | -23.1% | PE20x | |
| 241 Alibaba Health Information Technology | HK$3.59 | 4.7% +HK$2.6b | -28.1% | PE25.8x | |
| 1833 Ping An Healthcare and Technology | HK$7.83 | 4.8% +HK$765.6m | -35.0% | PE37.8x |